A detailed history of Credit Suisse Ag transactions in Merck & Co., Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 6,287,644 shares of MRK stock, worth $613 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
6,287,644
Previous 6,515,512 3.5%
Holding current value
$613 Million
Previous $710 Million 16.8%
% of portfolio
0.82%
Previous 0.7%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $25.8 Million - $30.1 Million
-227,868 Reduced 3.5%
6,287,644 $830 Million
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $80.7 Million - $87.9 Million
-805,938 Reduced 11.01%
6,515,512 $710 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $17.4 Million - $19.3 Million
168,675 Added 2.36%
7,321,450 $754 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $50.4 Million - $54.9 Million
-463,607 Reduced 6.09%
7,152,775 $825 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $7.58 Million - $8.46 Million
-73,619 Reduced 0.96%
7,616,382 $810 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $8.79 Million - $11.3 Million
-100,528 Reduced 1.29%
7,690,001 $853 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $17.1 Million - $19.2 Million
-201,743 Reduced 2.52%
7,790,529 $671 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $62.6 Million - $70.9 Million
749,609 Added 10.35%
7,992,272 $729 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $51.7 Million - $57.9 Million
-702,675 Reduced 8.84%
7,242,663 $594 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $42.6 Million - $53.3 Million
589,040 Added 8.01%
7,945,338 $609 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $1.94 Million - $2.13 Million
26,997 Added 0.37%
7,356,298 $553 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $13.6 Million - $15 Million
192,916 Added 2.7%
7,329,301 $566 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $7.61 Million - $8.97 Million
-110,550 Reduced 1.53%
7,136,385 $550 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $4.89 Million - $5.42 Million
68,081 Added 0.95%
7,246,935 $593 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $27.5 Million - $31.2 Million
375,937 Added 5.53%
7,178,854 $595 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $25.3 Million - $28.8 Million
359,401 Added 5.58%
6,802,917 $526 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $73.4 Million - $102 Million
-1,158,739 Reduced 15.24%
6,443,516 $496 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $123 Million - $139 Million
1,587,101 Added 26.39%
7,602,255 $691 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $43.8 Million - $47.8 Million
575,938 Added 10.59%
6,015,154 $506 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $30.1 Million - $35.1 Million
430,561 Added 8.6%
5,439,216 $456 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $54.1 Million - $61.7 Million
-777,057 Reduced 13.43%
5,008,655 $417 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $8.45 Million - $9.81 Million
-129,546 Reduced 2.19%
5,785,712 $442 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $13.3 Million - $15.7 Million
230,841 Added 4.06%
5,915,258 $420 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $59 Million - $69.3 Million
-1,160,668 Reduced 16.96%
5,684,417 $345 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $132 Million - $153 Million
-2,585,682 Reduced 27.42%
6,845,085 $373 Million
Q4 2017

Mar 14, 2018

BUY
$51.62 - $61.64 $19.6 Million - $23.4 Million
379,754 Added 4.2%
9,430,767 $531 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $189 Million - $225 Million
3,655,245 Added 67.74%
9,051,013 $509 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $9 Million - $9.68 Million
-153,374 Reduced 2.76%
5,395,768 $345 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,549,142
5,549,142 $356 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.